Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy. - Wikidata - awgldk - TriplyDB

Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.

Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.

http://www.wikidata.org/entity/Q37388149

about

Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1 Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice.Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice.Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function.West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses.The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma.Homology, similarity, and identity in peptide epitope immunodefinition.

P2860

Q33658400-3F5CF048-5375-4E58-86EF-EB836537CBC9 Q35005601-BD9C0CEF-7C74-4712-B3AF-DFF7AE9C5930 Q37274049-1062251A-25FA-468B-B1D3-0F360AFCB2E5 Q37404065-08219310-4DC2-44D2-929A-351C65A82A85 Q37613262-51E3C1DB-57CF-43DC-AE69-CAB381A84C65 Q40269573-48CBAC15-9875-41F1-9868-A83DCE6AF9AA Q40991410-3371EF24-F40D-474F-9688-CF8057F1B3F0 Q43025486-7984D9A0-E89D-4EBA-A454-654BF281230D Q43487466-7D32B91E-3287-4C2D-A7D6-27F483032F7A

P2860

Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.

http://www.wikidata.org/entity/Q37388149

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Autoimmune thyroiditis as an i ...... e during cancer immunotherapy.

@en

Autoimmune thyroiditis as an i ...... e during cancer immunotherapy.

@nl

type

label

Autoimmune thyroiditis as an i ...... e during cancer immunotherapy.

@en

Autoimmune thyroiditis as an i ...... e during cancer immunotherapy.

@nl

prefLabel

Autoimmune thyroiditis as an i ...... e during cancer immunotherapy.

@en

Autoimmune thyroiditis as an i ...... e during cancer immunotherapy.

@nl

P1433

Q37388149-FA264CD5-31CC-49D7-B61D-F6EEF9608A19

P1476

Q37388149-76C60733-640E-47D0-84B8-B1986EE84D96

P2093

Q37388149-220862CB-7CFF-489D-822B-8F6EBAA1AF29

Q37388149-480CF468-2207-4CE3-8BEE-E4156D9A9CF7

Q37388149-EB96F9BA-1D6D-43A9-B351-CD9362506812

Q37388149-FA36CEDE-286F-4A9D-ADBC-8BD764C2620D

P2860

Q37388149-02C44D4B-5649-4DD5-AF1D-1DEB3D669F3C

Q37388149-03317F87-4A05-4324-8F63-2CF77C44F360

Q37388149-0A6BC379-7959-4BAD-B383-3E7BC6FAC258

Q37388149-0DED08AE-079D-4C6B-9F84-C28AD0A8F76B

Q37388149-126D0A93-E87E-42C6-A89D-32B490E67CAE

Q37388149-340D1925-EC6D-477A-9FB2-41311F4E7A4B

Q37388149-42479B56-CDB9-4161-BE86-7C116FEE5746

Q37388149-594832B0-A1E8-47FF-8F8F-BC4F9782A9D2

Q37388149-5C43979A-D9AB-4E47-9BA2-C092787B4461

Q37388149-6E5EACC9-B4DA-4ED0-9082-CC4107D20A76

P304

Q37388149-39B3DEAC-AE21-4D63-AE58-37969D62845B

P31

Q37388149-F940A722-37EE-4490-A457-D596A2085BAD

P356

Q37388149-2C47017B-FE38-4B44-9DD4-ACB7B46E69C5

P433

Q37388149-773D5EAC-5D99-4DCB-8F2B-67C0AE9829C5

P478

Q37388149-9921D0C3-4C95-4F86-B359-1A2DB0D63E63

P50

Q37388149-C6DBCB28-ED3A-44EA-83CB-C00042388B20

P577

Q37388149-D132DA0C-7971-4F9D-884B-9928C9A1B00E

P5875

Q37388149-8B4E4089-C1D9-4634-8556-5642B4C8BFDA

P698

Q37388149-B2F87388-87FB-4A92-855D-7E264DCB35DA

P921

Q37388149-4DF5FE8A-5B0F-46A7-AC65-12F11E8D90BE

P932

Q37388149-588250A1-1548-480F-80E2-E2814D21A5A5

P356

J.AUTREV.2009.02.034

P1433

Autoimmunity Reviews

P1476

Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy

@en

P2093

Bruce E Elliott

http://www.w3.org/2001/XMLSchema#string

Jennifer B Jacob

http://www.w3.org/2001/XMLSchema#string

Wei-Zen Wei

http://www.w3.org/2001/XMLSchema#string

Yi-chi M Kong

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

Epidemiology and estimated population burden of selected autoimmune diseases in the United States.

Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease.

Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity.

Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade.

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer.

Tolerance to autoimmune thyroiditis: (CD4+)CD25+ regulatory T cells influence susceptibility but do not supersede MHC class II restriction.

HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene

Next generation of immunotherapy for melanoma.

P304

28-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AUTREV.2009.02.034

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

222133788

http://www.w3.org/2001/XMLSchema#string

P698

19254781

http://www.w3.org/2001/XMLSchema#string

P921

P932

2762207

http://www.w3.org/2001/XMLSchema#string